ArticlePloS one2013

Targeting tissular immune response improves diagnostic performance of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease.

Daniel Bertin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.